Cellular and Molecular Effects of High-Molecular-Weight Heparin on Matrix Metalloproteinase 9 Expression

Area of Science:

• Immunology
• Biochemistry
• Hematology

Background:

• Blood collection using anticoagulants can affect biomarker concentrations.
• Matrix metalloproteinase-9 (MMP-9) levels are crucial for diagnostics but can be influenced by sample handling.
• Understanding anticoagulant effects on MMP-9 is vital for accurate diagnostic validity.

Purpose of the Study:

• To investigate the impact of different anticoagulants on matrix metalloproteinase-9 (MMP-9) regulation.
• To identify specific cell types and molecular mechanisms involved in MMP-9 modulation by anticoagulants.
• To determine how anticoagulant-induced changes in MMP-9 affect diagnostic accuracy.

Main Methods:

• Co-culture experiments using THP-1 (monocytes), Jurkat (T cells), and HT (B cells) cell lines.
• Assessment of MMP-9 expression following treatment with ethylenediaminetetraacetic acid, citrate, and high-/low-molecular-weight heparin (HMWH, LMWH).
• Analysis of cytokine/chemokine secretion (IL-16, sICAM-1, IL-8) and their role in MMP-9 induction.

Main Results:

• High-molecular-weight heparin (HMWH) significantly induced MMP-9 expression in co-cultures of THP-1 and Jurkat cells.
• Supernatant from HMWH-treated Jurkat cells stimulated MMP-9 production in THP-1 cells, indicating monocytes as producers.
• Jurkat-derived IL-16 and soluble intercellular adhesion molecule-1 (sICAM-1) induced MMP-9 and IL-8 production by THP-1 cells.

Conclusions:

• HMWH in blood samples can lead to increased MMP-9 expression.
• This increase is likely mediated by HMWH-induced T-cell secretion of IL-16 and sICAM-1, which in turn stimulate monocyte MMP-9 and IL-8 production.
• IL-8 may contribute to MMP-9 expression through a positive autocrine feedback loop, impacting diagnostic validity.